Related Experiment Video
Updated: Dec 24, 2025

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
Published on: January 26, 2015
Mast cell activation syndrome
Nathalie Vacheron1, Tracy McClinton, Donna J Lynch-Smith
1University of Tennessee Health Science Center, College of Nursing, Memphis, Tennessee.
Mast cell activation syndrome (MCAS) is a complex autoinflammatory disease causing erratic mast cell behavior and diverse symptoms. Increased provider awareness and education are crucial for timely diagnosis and effective symptom management.
Area of Science:
- Immunology
- Autoinflammatory Diseases
Background:
- Mast cell activation syndrome (MCAS) is a systemic autoinflammatory condition characterized by mast cell dysfunction.
- The evolutionary origin and historical recognition of MCAS remain unclear.
- Patients may exhibit a wide spectrum of symptoms, ranging from allergic-like reactions to nonallergic manifestations.
Purpose of the Study:
- To highlight the diverse clinical presentations of MCAS.
- To emphasize the need for increased healthcare provider awareness and education regarding MCAS.
- To underscore the role of nurse practitioners in recognizing and managing MCAS.
Main Methods:
- This study presents a case series describing the varied symptoms observed in MCAS patients.
- It reviews the clinical characteristics and diagnostic challenges associated with MCAS.
Main Results:
- MCAS can manifest with a broad range of symptoms, often leading to misdiagnosis or delayed diagnosis.
- The condition may affect a significant portion of the population, with symptom severity varying widely.
- Early recognition by primary care providers, including nurse practitioners, is essential.
Conclusions:
- There is a critical need for enhanced provider education to improve MCAS diagnosis and management.
- Nurse practitioners are pivotal in identifying patterns, validating patient experiences, and contributing to diagnostic consensus for MCAS.
- Current treatment focuses on symptom management, as no cure exists for MCAS.
Related Concept Videos
Sympathetic Activation
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction

